Abstract
The human IL-3 receptor is composed of both α and β subunits. In early studies, we showed that the level of IL-3Rβ expression was lower in patients with acute promyelocytic leukemia (APL) than healthy donors and patients in complete remission by real-time quantitative polymerase chain reaction (RT-qPCR). With the differentiation of cells, enhanced expression of IL-3Rβ was also observed in all-trans-retinoic acid (ATRA)-induced NB4 cells. To unravel the role of IL-3Rβ upregulation in NB4 cells induced with ATRA, we knocked down IL-3Rβ expression by RNA interference (RNAi). Knockdown of IL-3Rβ resulted in decreased proliferation in NB4 cells induced with or without ATRA, observed by cell growth curves, colony formation assays and cell cycle analysis. Surface expression of CD11b antigen and nitroblue tetrazolium (NBT) reduction assays were also carried out at different time points. However, no significant difference was observed between the experimental and control groups treated with ATRA. Other findings suggested that IL-3Rα was decreased in NB4-IL-3Rβ shRNA cells by western blot. Down-regulation of IL-3Rβ also caused a decrease in PML/RARα expression detected with RT-qPCR. Together, these results suggest that abnormalities of IL-3Rβ expression were observed in APL; knockdown of IL-3Rβ inhibited the proliferation of NB4 cells with or without ATRA, but no effect was detected in the cellular differentiation. When NB4 cells exposed to ATAR, the up-regulation of IL-3Rβ expression may contribute to the maintenance of proliferation rather than cell differentiation.
Similar content being viewed by others
References
Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood. 1993;82(12):3515–23.
Militi S, Riccioni R, Parolini I, Sposi NM, Samoggia P, Pelosi E, Testa U, Peschle C. Expression of interleukin 3, granulocyte–macrophage colony-stimulating factor receptor common chain βc, βIT in normal haematopoiesis: lineage specificity, proliferation-independent induction. Br J Haematol. 2000;111(2):441–51.
Begley CJ, Woodcock JM, Stovoski FC, Lopez AF. The structural and functional basis of cytokine receptor activation: lessons from the common subunit of the granulocyte-macrophage colony stimulating factor, interleukin-3 and IL-5 receptors. Blood. 1997;89:1471–82.
Miyajima A, Mui AL, Ogorochi T, Sakamaki K. Receptors for granulocyte–macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood. 1993;82:1960–74.
Kitamura T, Sato N, Arai K, Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals shared beta subunit for the human IL-3 and GM-CSF receptors. Cell. 1991;66:1165–74.
Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A, Rao P, Kitamura T, Miyajima A, Mufson RA. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA. 1990;87(24):9655–9.
Hallek M, Lepisto EM, Slattery KE, Griffin JD, Ernst TJ. Interferon-g increases the expression of the gene encoding the b subunit of the granulocyte-macrophage colony-stimulating factor receptor. Blood. 1992;80:1736–42.
Watanabe Y, Kitamura T, Hayashida K, Miyajima A. Monoclonal antibody against the common β subunit (βc) of the human interleukin (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor receptors shows up-regulation of βc by IL-1 and tumor necrosis factor-a. Blood. 1992;80:2215–24.
Liboi E, Jubinsky P, Andrews NC, Nathan DG, Mathey-Prevot B. Enhanced expression of the interleukin-3 and granulocyte-hematopoietic cells stimulated with haematopoietic growth factors. Blood. 1992;80:1183–9.
Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med. 2002;347:1593–603.
Hahn WC, Weinberg RA. Modelling the molecular circuity of cancer. Nat Rev Cancer. 2002;2:331–41.
Testa U, Riccioni R, Diverio D, Rossini A, Lo Coco F, Peschle C. Interleukin-3 receptor in acute leukemia. Leukemia. 2004;18(2):219–26.
Mc Cormack MP, Gonda TJ. Expression of activated mutants of the human interleukin-3/interleukin-5/granulocyte–macrophage colony-stimulating factor receptor common β subunit in primary hematopoietic cells induces factor-independent proliferation and differentiation. Blood. 1997;90:1471–81.
Hannemann J, Hara T, Kawai M, Miyajima A, Ostertag W, Stocking C. Sequential mutations in the interleukin-3 (IL3)/granulocyte-macrophage colony-stimulating factor/IL5 receptor beta-subunit genes are necessary for the complete conversion to growth autonomy mediated by a truncated beta C subunit. Mol Cell Biol. 1995;15(5):2402–12.
Allam M, Renzi PM. Inhibition of GM-CSF/IL-3/IL-5 signaling by antisense oligodeoxynucleotides targeting the common beta chain of their receptors. Antisense Nucleic Acid Drug Dev. 2001;11(5):289–300.
Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S, Bloomfield CD, Appelbaum FR, Tallman MS, Slack JL, Willman CL. Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood. 2003;101(7):2521–8. (Epub 2002 Dec 5).
Yao L, Chen ZX, Cen JN, Qiu QC, He J, Bao XJ, Yuan XN. Determination of the common molecular markers in newly diagnosed leukemias by using real-time quantitative RT-PCR. Zhonghua Xue Ye Xue Za Zhi. 2008;29(3):192–5.
Testa U, Riccioni R, Militi S, Coccia E, Stellacci E, Samoggia P, et al. Elevated expression of IL-3Ra in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood. 2002;100:2980–8.
Munoz L, Nomdedeu JF, Lopez O, Carnicer MJ, Bellido M, Aventin A, et al. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica. 2001;86:1261–9.
Wang J, Wang Q, Chen X. Study on the sensitization of acute myeloid leukemia cell to daunorubicin by recombinant human interleukin-3. Zhonghua Xue Ye Xue Za Zhi. 1999;20(1):30–2.
Riccioni R, Diverio D, Riti V, Buffolino S, Mariani G, Boe A, Cedrone M, Ottone T, Foà R, Testa U. Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor. Br J Haematol. 2009;144(3):376–87. Epub 2008 Nov 13.
Diverio D, Riccioni R, Mandelli F, Lo Coco F. The PML/RAR alpha fusion gene in the diagnosis, monitoring of acute promyelocytic leukemia. Haematologica. 1995;80(2):155–60.
Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93:3167–215.
Le Beau MM, Davis EM, Patel B, Phan VT, Sohal J, Kogan SC. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia. Blood. 2003;102(3):1072–4. (Epub 2003 Apr 10).
Le Beau MM, Bitts S, Davis EM, Kogan SC. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. Blood. 2002;99(8):2985–91.
Phan VT, Shultz DB, Truong B-TH, et al. Cooperation of cytokine signaling with chimeric transcription factors in leukemogenesis: PML-RAR blocks growth factor mediated differentiation. Mol Cell Biol. 2003;23(13):4573–85.
Acknowledgments
This work was sponsored by the Foundation of Fujian Province Key Laboratory of Hematology (Grant No. 2009J1004) and the Natural Science Foundation of Fujian Province (Grant No. C0820001).
Author information
Authors and Affiliations
Corresponding author
Additional information
X. Li and Y. Wu contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Li, X., Wu, Y. & Chen, Y. Down-regulating the expression of IL-3Rβ interfered with the proliferation, not differentiation in NB4 cells. Int J Hematol 93, 83–90 (2011). https://doi.org/10.1007/s12185-010-0751-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-010-0751-1